No correlation was observed between HNF3β protein expression and other clinicopathological characteristics, including patient's gender (P = 0.673), age (P = 0.495), tumor histological type (mucinous adenocarcinoma cf. adenocarcinoma, P = 0.601), and differentiation status (P = 0.107). This evidence concerns the gene FOXA2 and adenocarcinoma.